EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy

Giusy Tiseo, Valentina Galfo, Sergio Carbonara, Andrea Marino, Giovanni Di Caprio, Anna Carretta, Alessandra Mularoni, Michele Fabiano Mariani, Alberto Enrico Maraolo, Riccardo Scotto, Lidia Dalfino, Lorenzo Corbo und 26 weitere

Infection · 2025

DOI: 10.1007/s15010-024-02423-6 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Infection, 2025. Verfasst von Giusy Tiseo und 37 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Bacteremia, Gram-Negative Bacterial Infections, Healthcare-Associated Pneumonia, Gram-Negative Bacteria. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Merck Sharp and Dohme Italia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To describe the clinical characteristics and outcomes of patients with nosocomial pneumonia (NP) caused by carbapenem-resistant Gram-negative bacilli (CR-GNB) and to compare them to patients with NP caused by carbapenem-susceptible (CS)-GNB. METHODS: Prospective observational multicenter study including patients with bacteremic NP caused by GNB from the ALARICO Network (June 2018-January 2020). The primary outcome measure was 30-day mortality. A Cox regression analysis was performed to identify factors independently associated with 30-day mortality. Hazard ratio (HR) and 95% confidence intervals (CI) were calculated. RESULTS: Overall, 167 patients with GNB NP were included: 101 with bacteremic NP caused by CR-GNB (n = 39 by KPC-producing Klebsiella pneumoniae, n = 29 by carbapenem-resistant Acinetobacter baumannii, n = 28 by carbapenem-resistant Pseudomonas aeruginosa, n = 5 by MBL-producing Klebsiella pneumoniae) and 66 cases of bacteremic CS-GNB NP. Thirty-day mortality rate was higher in patients with NP caused by CR-GNB compared to those with NPcaused by CS-GNB (46.5% vs 30.3%, p = 0.036). On multivariable analysis, age (HR 1.044, 95% CI 1.021-1.067, p < 0.001), hematological malignancy (HR 4.307, 95% CI 1.924-9.643, p < 0.001) and septic shock (HR 3.668, 95% CI 2.001-6.724, p < 0.001) were factors independently associated with 30-day mortality, while the receipt of adequate antibiotic therapy within 24 h from infection onset (HR 0.495, 95% CI 0.252-0.969, p = 0.04) was a protective factor. Carbapenem resistance was not associated with increased risk of mortality (HR 1.075, 95% CI 0.539-2.142, p = 0.837). CONCLUSIONS: Patients with bacteremic NP caused by CR-GNB have high mortality rate. Strategies to reduce the time from infection to the administration of adequate antibiotic therapy should be implemented in patients with NP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaGram-Negative Bacterial InfectionsHealthcare-Associated PneumoniaGram-Negative BacteriaCross InfectionHumansMaleFemaleItalyAgedProspective StudiesMiddle AgedAnti-Bacterial AgentsAged, 80 and overCarbapenemsRisk FactorsKlebsiella pneumoniae

Stichwörter der Autor:innen

Acinetobacter baumanniiKlebsiella pneumoniaePseudomonas aeruginosaCarbapenem-resistanceGram-negative bacilliMultidrug resistance

Substanzen

Anti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.
  • Infectious Disease Unit, ASL BT, Bisceglie, Italy.
  • Unit of InfectiousDiseases, ARNAS Garibaldi, Department of Clinical and Experimental Medicine, Nesima Hospital, University of Catania, Catania, Italy.
  • Infectious Diseases Unit, AORN Sant' Anna e San Sebastiano, Caserta, Italy.
  • Infectious Diseases Unit, Department of Clinical and Surgical Sciences, University of Foggia, AOU Policlinico Riuniti Foggia, Foggia, Italy.
  • Department of Infectious Diseases, Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT), Palermo, Italy.

Förderung

  • Merck Sharp and Dohme Italia

Zitieren

APA

Tiseo, G., Galfo, V., Carbonara, S., Marino, A., Di Caprio, G., Carretta, A., Mularoni, A., Mariani, M. F., Maraolo, A. E., Scotto, R., Dalfino, L., Corbo, L., Macera, M., Medaglia, A. A., d'Errico, M. L., Gioè, C., Sgroi, C., Del Vecchio, R. F., Ceccarelli, G., …, & ALARICO Network (2025). Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy. Infection. https://doi.org/10.1007/s15010-024-02423-6

Vancouver

Tiseo G, Galfo V, Carbonara S, Marino A, Di Caprio G, Carretta A, et al. Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy. Infection. 2025. doi:10.1007/s15010-024-02423-6

BibTeX
@article{Tiseo2025,
  author = {Tiseo, Giusy and Galfo, Valentina and Carbonara, Sergio and Marino, Andrea and Di Caprio, Giovanni and Carretta, Anna and Mularoni, Alessandra and Mariani, Michele Fabiano and Maraolo, Alberto Enrico and Scotto, Riccardo and Dalfino, Lidia and Corbo, Lorenzo and Macera, Margherita and Medaglia, Alice Annalisa and d'Errico, Maria Luca and Gioè, Claudia and Sgroi, Christian and Del Vecchio, Rosa Fontana and Ceccarelli, Giancarlo and Albanese, Antonio and Buscemi, Calogero and Talamanca, Simona and Foti, Giuseppe and De Stefano, Giulio and Franco, Antonina and Iacobello, Carmelo and Corrao, Salvatore and Morana, Domenico and Pieralli, Filippo and Gentile, Ivan and Santantonio, Teresa and Cascio, Antonio and Coppola, Nicola and Cacopardo, Bruno and Venditti, Mario and Menichetti, Francesco and Falcone, Marco and ALARICO Network, ALARICO Network},
  title = {Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy},
  journal = {Infection},
  year = {2025},
  doi = {10.1007/s15010-024-02423-6}
}
Kostenlos starten →